Founders Financial Alliance LLC cut its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 20.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,128 shares of the company’s stock after selling 2,053 shares during the period. Founders Financial Alliance LLC’s holdings in BlackRock Health Sciences Trust were worth $332,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. grew its stake in BlackRock Health Sciences Trust by 0.8% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 50,106 shares of the company’s stock worth $2,027,000 after purchasing an additional 410 shares during the period. Karpus Management Inc. bought a new stake in shares of BlackRock Health Sciences Trust in the 4th quarter valued at $728,000. Janney Montgomery Scott LLC lifted its position in shares of BlackRock Health Sciences Trust by 8.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 27,837 shares of the company’s stock valued at $1,154,000 after acquiring an additional 2,122 shares during the period. HBK Sorce Advisory LLC lifted its position in shares of BlackRock Health Sciences Trust by 14.4% during the 1st quarter. HBK Sorce Advisory LLC now owns 7,009 shares of the company’s stock valued at $290,000 after acquiring an additional 884 shares during the period. Finally, Raymond James & Associates boosted its stake in BlackRock Health Sciences Trust by 7.0% during the second quarter. Raymond James & Associates now owns 44,877 shares of the company’s stock worth $1,833,000 after acquiring an additional 2,931 shares in the last quarter.
BlackRock Health Sciences Trust Stock Up 0.4 %
BME opened at $42.08 on Wednesday. The company has a fifty day moving average price of $41.65 and a two-hundred day moving average price of $40.71. BlackRock Health Sciences Trust has a 1-year low of $35.53 and a 1-year high of $42.86.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Read More
- Five stocks we like better than BlackRock Health Sciences Trust
- Comparing and Trading High PE Ratio Stocks
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.